GRAIL, Inc.
NASDAQ:GRALMedical - Diagnostics & Research
+$1.90 today
- Market cap
- $4.59B
- Beta
- 3.16
- P/E (TTM)
- -6.3
- EPS (TTM)
- -$9.73
Volume 0.62M
Average 0.77M
GRAL Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
GRAIL, Inc.NASDAQ: GRAL
Accounts Payables · Q2 FY2026 · quarter ended Jun 2026
Accounts payables growth accelerates
Q2 FY2026 accounts payables of $2.56M rose 401.4% year over year, ahead of the +138.2% change in trailing-twelve-month accounts payables. Sequentially, it fell 2.9% from the prior quarter.
Context
- Accounts payables amounted to 1.9% of revenue in FY2025, down 9.8 pp from a year earlier.
- Accounts payables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +401.4% holds above the trailing-twelve-month pace of +138.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- (2.73M) USD
- Year-over-year change
- +81.3%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (2.73M) | +81.3% |
| FY2024 | 2024-12-31 | (14.64M) | -606.6% |
| FY2023 | 2023-12-31 | 2.89M | +23.5% |
| FY2022 | 2022-12-31 | 2.34M | +80.4% |
| FY2021 | 2021-12-31 | 1.3M | — |
Accounts Payables vs competitors
How GRAL compares with its peers on the latest reported figures
- GRAL's LTM Jun 2026 accounts payables of $3.79M is the 7th largest of the 10 companies compared; the peer median is $3.33M.
- Its year-over-year change of +138.2% is the 5th highest of 8, against a peer median of +235.6%.
- Accounts payables amounts to 2.3% of revenue for GRAL, versus a peer median of 1.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $41.71M | — | — | 3.3% | |
| LTM Jun 2026 | $29.39M | +734.8% | -48.3% | 1.1% | |
| LTM Jun 2026 | $16.49M | -289.5% | — | 2.2% | |
| LTM Mar 2026 | $5.66M | +269.6% | +74.2% | 1.7% | |
WGSGeneDx Holdings Corp. | LTM Jun 2026 | $5.65M | -882.7% | -29.5% | 1.2% |
| LTM Mar 2026 | $4M | +385.7% | -26.3% | 0.5% | |
| LTM Jun 2026 | $3.79M | +138.2% | — | 2.3% | |
BLLNBillionToOne, Inc. | LTM Jun 2026 | $3.33M | — | — | 0.8% |
| LTM Mar 2026 | $1.73M | +235.6% | +13.8% | 2.7% | |
| LTM Mar 2026 | $800K | -69.8% | — | 0.2% | |
| Peer median (excluding GRAL) | $3.33M | +235.6% | -26.3% | 1.2% | |
Competitors are the stored peer set for GRAL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (1.25B) | (5.4B) | (1.47B) | (2.03B) | (408.35M) |
| Depreciation & Amortization | 58.45M | 154.76M | 158.7M | 158.06M | 156.34M |
| Deferred Income Tax | 0 | (39.06M) | (38.15M) | (134.25M) | (126.15M) |
| Stock-Based Compensation | 681.91M | 75.73M | 97.24M | 86.08M | 58.28M |
| Change in Working Capital | 21.59M | (14.46M) | 7.72M | (24.28M) | 12.41M |
| Accounts Receivables | (6.88M) | (8.68M) | (1.38M) | (3.37M) | 1.69M |
| Inventory | (5.67M) | (14.08M) | (1.94M) | 3.07M | 2.62M |
| Accounts Payables | 1.3M | 2.34M | 2.89M | (14.64M) | (2.73M) |
| Other Working Capital | 32.85M | 5.95M | 8.16M | (9.35M) | 10.84M |
| Other Non-Cash Items | (201M) | 4.66B | 644.39M | 1.36B | 8.46M |
| Operating Cash Flow | (688.13M) | (561.31M) | (595.8M) | (577.16M) | (299.01M) |
| Capital Expenditures | (69.93M) | (22.86M) | (12.89M) | (5.21M) | (909K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | (545.8M) | (1.31B) |
| Sales of Investments | 0 | 0 | 0 | 0 | 1.22B |
| Other Investing Activities | 414.74M | 0 | 0 | 0 | 0 |
| Investing Cash Flow | 344.81M | (22.86M) | (12.89M) | (551.01M) | (85.05M) |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 5.98M | 0 | 0 | 0 | 423.32M |
| Common Stock Repurchased | (170K) | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 388.93M | 604.82M | 463.77M | 1.24B | 0 |
| Financing Cash Flow | 394.74M | 604.82M | 463.77M | 1.24B | 423.32M |
| Effect of Forex Changes | (194.61M) | (511K) | 305K | (62K) | (147K) |
| Net Change in Cash | (143.19M) | 20.13M | (144.62M) | 116.07M | 39.12M |
| Free Cash Flow | (758.06M) | (584.17M) | (608.69M) | (582.36M) | (299.01M) |
GRAIL, Inc.
NASDAQ:GRAL
Intrinsic Alpha fair value
Locked
Current Price
$102.10
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.